Sep 10, 2026 01:11AM
Sep 10, 2026 01:11AM
Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM
Mar 18, 2026 09:00AM
Dec 16, 2025 08:30AM
Nov 3, 2025 09:00AM Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025
Oct 13, 2025 09:00AM
Sep 18, 2025 10:00AM
Aug 4, 2025 08:00AM
Jul 24, 2025 09:00AM
Jan 13, 2025 01:00AM
Jan 9, 2025 01:00AM
Nov 25, 2024 01:00AM Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA
Nov 5, 2024 09:15AM
Oct 18, 2024 02:13PM
Oct 8, 2024 01:00AM
Jun 18, 2024 01:00AM
Apr 10, 2024 01:00AM
Dec 9, 2023 11:30AM
Nov 20, 2023 01:00AM Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges
Sep 6, 2023 01:00AM
Jun 27, 2023 09:03AM
Mar 6, 2023 01:00AM
Dec 11, 2022 01:02AM
Nov 14, 2022 08:33PM
Nov 10, 2022 08:05AM
Nov 3, 2022 09:00AM Genentech to Present Data at ASH 2022 Showcasing Strength of Hematology Portfolio and Expanding Into New Areas to Address More Patient Needs
Sep 19, 2022 01:43PM
Sep 19, 2022 01:40PM
Aug 11, 2022 01:00AM
Jul 22, 2022 07:03AM
Jul 11, 2022 05:45AM
Dec 17, 2021 08:00AM
Dec 13, 2021 01:00AM Interim Data From Phase III HAVEN 6 Study Demonstrate Favorable Safety and Efficacy Profile of Genentech’s Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A
Nov 23, 2021 09:15AM
Oct 18, 2021 01:00AM
Jul 19, 2021 01:00AM
Jun 18, 2021 11:42AM
Jun 18, 2021 11:30AM
May 18, 2021 01:00AM
Mar 9, 2021 01:00AM Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
Feb 11, 2021 10:02AM
Feb 11, 2021 10:00AM
Feb 8, 2021 12:00PM
Feb 8, 2021 12:00PM
Dec 1, 2020 11:30AM
Oct 29, 2020 12:45PM
Sep 18, 2020 01:00AM Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia
Aug 17, 2020 02:00AM

331,394 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All